AKT/mTOR Signal Cascade and Expression of PD-1, PD-L1, and PD-L2 in Gastric Cancer

被引：6
|
作者：
Spirina, L. V. [1 ,2 ]
Avgustinovich, A. V. [1 ]
Afanas'ev, S. G. [1 ]
Kondakova, I. V. [1 ]
Volkov, M. Yu. [1 ]
Dobrodeev, A. Yu. [1 ]
Boronkina, A. I. [2 ]
机构：
[1] Tomsk Natl Res Med Ctr, Canc Res Inst, Tomsk, Russia
[2] Siberian State Med Univ, Minist Hlth Russian Federat, Tomsk, Russia
来源：
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE | 2020年 / 170卷 / 01期
关键词：
gastric cancer; AKT; mTOR signaling cascade; PD; PD-L1; PD-L2; PATHWAY; AKT;
D O I：
10.1007/s10517-020-05007-0
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
The peculiarities of gastric cancer development associated with the expression levels of components of the AKT/mTOR signaling cascade and PD, PD-L1, PD-L2 have not yet been identified. We revealed the fundamental changes in the expression AKT/mTOR and PD receptors and their ligands associated with dissemination of gastric cancer. An increase in the mRNA level of all components of this cascade was demonstrated. The expression of mTOR and AKT decreased against the background of enhanced expression of PTEN phosphatase. The increase in the expression of PD-1 receptors and PD-L1 and PD-L2 ligands was most pronounced in patients with distant metastases.
引用
收藏
页码：75 / 78
页数：4
相关论文
共 50 条
  • [41] Prognostic significance of PD-L1 and PD-L2 in breast cancer
    Baptista, Mauricio Z.
    Sarian, Luis Otavio
    Derchain, Sophie F. M.
    Pinto, Glauce A.
    Vassal, Jose
    HUMAN PATHOLOGY, 2016, 47 (01) : 78 - 84
  • [42] PD-L1 and PD-L2 Protein Expression is Frequently Discordant in Breast Cancer
    Chaudhary, Lubna
    Jorns, Julie
    Sun, Yunguang
    Kamaraju, Sailaja
    Cheng, Yee Chung
    Kong, Amanda
    Yen, Tina
    Patten, Caitlin
    Cortina, Chandler
    Chervoneva, Inna
    Chitambar, Christopher
    Rui, Hallgeir
    CANCER RESEARCH, 2024, 84 (09)
  • [43] Integrative assessment of clinicopathological parameters and the expression of PD-L1, PD-L2 and PD-1 in tumor cells of retroperitoneal sarcoma
    Miyake, Makito
    Oda, Yuki
    Nishimura, Nobutaka
    Morizawa, Yosuke
    Ohnishi, Sayuri
    Hatakeyama, Kinta
    Fujii, Tomomi
    Hori, Shunta
    Gotoh, Daisuke
    Nakai, Yasushi
    Anai, Satoshi
    Torimoto, Kazumasa
    Tsukamoto, Shinji
    Fujii, Hiromasa
    Kido, Akira
    Honoki, Kanya
    Matsumura, Yoshiaki
    Okajima, Eijiro
    Tanaka, Nobumichi
    Fujimoto, Kiyohide
    ONCOLOGY LETTERS, 2020, 20 (05)
  • [44] PD-1 AND PD-L1 EXPRESSION ON THE PROGNOSIS OF OVARIAN CANCER
    Li, R. P.
    Li, W. Y.
    Guo, Y. Z.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2019, 33 (04): : 1161 - 1166
  • [45] Expression of PD-1 and Its Ligands, PD-L1 and PD-L2, in Smokers and Never Smokers with KRAS-Mutant Lung Cancer
    Calles, Antonio
    Liao, Xiaoyun
    Sholl, Lynette M.
    Rodig, Scott J.
    Freeman, Gordon J.
    Butaney, Mohit
    Lydon, Christine
    Dahlberg, Suzanne E.
    Hodi, F. Stephen
    Oxnard, Geoffrey R.
    Jackman, David M.
    Jaenne, Pasi A.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (12) : 1726 - 1735
  • [46] The PD-1 pathway in systemic lupus erythematosus: The Ligands of PD-1, PD-L1 and PD-L2, are also susceptibility factors.
    Abelson, AK
    Johansson, C
    Kozyrev, S
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S203 - S203
  • [47] Immune Checkpoint (PD-1, PD-L1, PD-L2, and CTLA-4) Expression in Plasma Cell Myeloma
    Lee, Min Young
    Park, Chan-jeoung
    Cho, Young-Uk
    You, Eunkyoung
    Jang, Seongsoo
    Lee, Jung-Hee
    Hong, Jung Yong
    Yoon, Dok Hyun
    Suh, Cheolwon
    BLOOD, 2017, 130
  • [48] Clinical Value of the PD-1/PD-L1/PD-L2 Pathway in Patients Suffering from Endometriosis
    Suszczyk, Dorota
    Skiba, Wiktoria
    Zardzewialy, Witold
    Pawlowska, Anna
    Wlodarczyk, Karolina
    Polak, Grzegorz
    Tarkowski, Rafal
    Wertel, Iwona
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (19)
  • [49] Structural Biology of the Immune Checkpoint Receptor PD-1 and Its Ligands PD-L1/PD-L2
    Zak, Krzysztof M.
    Grudnik, Przemyslaw
    Magiera, Katarzyna
    Domling, Alexander
    Dubin, Grzegorz
    Holak, Tad A.
    STRUCTURE, 2017, 25 (08) : 1163 - 1174
  • [50] High-affinity PD-1 molecules deliver improved interaction with PD-L1 and PD-L2
    Li, Yanyan
    Liang, Zhaoduan
    Tian, Ye
    Cai, Wenxuan
    Weng, Zhiming
    Chen, Lin
    Zhang, Huanling
    Bao, Yifeng
    Zheng, Hongjun
    Zeng, Sihai
    Bei, Chunhua
    Li, Yi
    CANCER SCIENCE, 2018, 109 (08): : 2435 - 2445
12345